MarginsXMarginsX
Home › Markets › Industrials › RVTY

Revvity Inc. (RVTY)

RVTY trades on NYSE in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$148.85
-3.59% on the day
Market cap
$16.6B
Large cap
Revenue · 2025
$2.9B
+3.7% on 2024
Net income · 2025
$241.2M
8.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-28, https://www.sec.gov/Archives/edgar/data/31791/000003179126000012/0000031791-26-000012-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-28.

Profile

FieldValue
TickerRVTY on NYSE
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000031791
SEC industry codeLaboratory Analytical Instruments
Incorporated inMA

Financials · 2025

LineValue
Revenue$2.9B
Net income$241.2M
Operating income$356.6M
Net margin8.4%
Operating margin12.5%
Revenue growth+3.7%
Cash$919.9M
Total assets$12.2B
P/E (computed)68.9×
P/S (computed)5.8×

Warning signs

Cash runway
Cash-flow positive
$592.8M cash at October 4, 2026
Share count, 1 year
-1.5%
2025-10-31 to 2026-11-06 · -9.5% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
-$6.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$592.8M cash; operating cash flow $164.0M a quarter.Report 2026-10-04
Shares outstanding111,638,757 (2026-11-06); 113,375,621 a year earlier; 123,407,288 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-07-20
AuditorDeloitte & Touche LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $6.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-10-04
$728.9M$62.3M$166.7M$592.8M$2.6B$2.9B10-Q 2026-11-10
Q2 2026
2026-07-05
$729.7M$51.8M$191.9M$1.0B$3.2B$2.9B10-Q 2026-08-11
Q1 2026
2026-04-05
$711.1M$40.7M$115.2M$860.3M$3.2B$2.9B10-Q 2026-05-12
Q4 2025
2025-12-28
$772.1M$98.4M$182.0M$919.9M$3.2B$2.9B10-K 2026-02-24
Q3 2025
2025-09-28
$698.9M$46.7M$138.5M$931.4M$3.2B$2.8B10-Q 2026-11-10
Q2 2025
2025-06-29
$720.3M$53.9M$134.3M$991.8M$3.2B$2.8B10-Q 2026-08-11
Q1 2025
2025-03-30
$664.8M$42.2M$128.2M$1.1B$3.2B$2.8B10-Q 2026-05-12
Q4 2024
2024-12-29
$729.4M$94.6M$174.2M$1.2B$3.2B$2.8B10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2025-02-28
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-13
Latest proxyDEFA14A2026-03-16

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.5%
1 month-0.4%
3 months+31.4%
Year to date+59.6%
1 year+65.3%
From 52-week high-6.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
AVTRAvantor Inc.$15.32-1.42%$10.4B
BIOBio-Rad Laboratories Inc.$360.26-1.67%$9.7B
BRKRBruker Corporation$60.62-1.57%$9.3B
MTDMettler-Toledo International Inc.$1727.26-0.67%$34.4B
TXG10x Genomics Inc.$54.99-5.50%$7.2B
WATWaters Corporation$453.42-1.48%$44.6B
AAgilent Technologies Inc.$172.92-0.60%$48.8B
ALMRAlamar Biosciences Inc.$30.55-0.84%$2.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier